HM Venture Partners — Full Portfolio

Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.

BiotechDigital HealthMedical DevicesSan Diego, US

Litain Yeh(Co-Founder & Chief Executive Officer)Shunqi Yan(Co-Founder & Chief Operating Officer)

BiotechLaguna Hills, US

Litain Yeh(Executive Officer, Director, Promoter)Shunqi Yan(Executive Officer, Director, Promoter)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)

BoardZhang Mingyuan(Director)

Co-investorsHighlight Capital

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology.

BiotechDeep TechHealthtech

Baohua Huang(Founder & CEO)

GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.

AI & Machine LearningBiotechHealthtechMedical DevicesBeijing, CN

Board吕强兰炯

Co-investorsPan-Lin Capital

DCB technology company for gastrointestinal stenosis.

GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel.

BiotechHealthtechMedical DevicesPlymouth, US

Lixiao Wang(Founder & Chief Executive Officer)Ian Schorn(Chief Operational Officer)James Ness(Chief Financial Officer)Harrison Malinoff(VP of Operations and Quality)Dave Hendrickson(VP of Research & Development)Drew McClure(VP of Market Development)

HuidaGene develops CRISPR and RNA-guided gene editing technologies for therapeutic applications in neurology, ophthalmology, otology, myology, and hepatology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesShanghai, CN

Hui Yang(Co-Founder and Chief Scientific Advisor)

Hypertension company acquired by Novo Nordisk.

KBP is a biotechnology research and development organization that discovers and develops new therapies for unmet medical needs.

Biotech

Co-investorsBay City Capital

Laborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.

FemTechHealthtechMedical Devices

Chris(President & CEO)

Melodi Health is a medical device company focused on breast reconstruction and breast procedures, developing implantable combination devices with expertise in infection control and plastic reconstructive surgery.

FemTechHardwareHealthtechMedical DevicesMinneapolis, US

Sarah Worrell(Co-founder & Chief Executive Officer)inMichele Hilmer(Chief Strategy Officer)Hunter Moyer, MD(Chief Medical Officer)Kaitlyn Roth(VP Operations)inMatthew Hemsley(Director)Arikha Moses(Director)

Co-investorsEngage Venture Partners

HealthtechStewartville, US

David A. Jonas(Executive Officer, Director)Philip Conway(Executive Officer, Director)Sarah L. Grinde(Executive Officer, Director)

BoardAnthony Conway(Director)

Minnesota Medical Technologies develops and manufactures continence care products, specifically fecal incontinence management devices for individual patients.

Digital HealthHealthtechMedical DevicesStewartville, US

Philip J Conway(Executive Vice President – Operations (Founder))Sarah L Grinde(VP Marketing and Research & Development (Founder))Anthony J Conway(Chairman of the Board (Founder))Lonnie M Boe(Executive Secretary/Office Manager (Founder))

Neurotronic is developing Neuviant Multi-organ Denervation (MDN), an investigational catheter-based therapy that delivers ethanol to overactive sympathetic nerves near the kidneys and liver to lower blood sugar and blood pressure.

Newswise is a news distribution platform and press release service that connects journalists, public relations professionals, and the public with research news and expert sources across medical, science, life, and business sectors.

Marketing TechMedia & EntertainmentSaaS

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies.

BiotechHealthtechCopenhagen, DK

Maziar Mike Doustdarin

Co-investorsNovo Holdings

OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.

BiotechHealthtechRockville, US

Yang Liu(Co-founder)inPan Zheng(Co-founder)inMartin Devenport(Executive Officer)Michael Flaschen(Director)

Co-investors3E Bioventures Capital

First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.

BiotechRockville, US

Pan Zheng(Executive Officer)Yang Liu(Executive Officer, Director)Martin Devenport(Executive Officer)

BoardMiao Hong(Director)Karen Liu(Director)inKun-Liang Guan(Director)

Co-investors3E Bioventures Capital

BiotechDallas, US

David Thompson(Executive Officer, Director)inBrian de Beaubien(Executive Officer, Director)Renee Ryan(Director)Jude Paganelli(Executive Officer, Director)

BoardMartin Sands(Director)Judson Cooper(Director)

Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections.

BiotechDigital HealthHealthtechMedical Devices

Brian de Beaubien, MD(Co-Founder & Chief Medical Officer)David Thompson(Chairman & CEO)

Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.

BiotechDigital HealthHealthtech

David Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)Thierry Chauche(Chief Financial Officer)Marie O'Farrell(Chief Scientific Officer)Elizabeth Rozek(Chief Legal & Administrative Officer)

Co-investorsAltium CapitalKleiner PerkinsNew Enterprise Associates (NEA)

Merck is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.

BiotechHealthtechMedical DevicesRahway, US

Co-investorsAisling CapitalAtlas VentureSanderling VenturesSPRINGROCK VENTURESThe Column Group

UC Davis is a public tier-one research university located in Davis, California, with additional campuses and centers including UC Davis Health in Sacramento and marine and environmental research labs.

EdTechDavis, US

Co-investorsDigitalDx VenturesThe March Group

Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.

HealthtechMedical DevicesPlymouth, US

Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)

Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure.

HealthtechMedical DevicesSanta Barbara, US

Terry Buelna(Chief Executive Officer/President/CFO)

BoardWayne Wu(Director)

BioNTech develops immunotherapies that use the body's immune system to treat cancer, infectious diseases, and other serious illnesses.

BiotechHealthtech

Co-investorsPfizer Venture InvestmentsSalvia

Zepto develops a targeted liquid biopsy platform for infectious disease diagnostics, offering plasma-based molecular testing through its CLIA reference laboratory and an integrated sample-to-result platform for use in hospital laboratories.

BiotechHealthtechMedical Devices